Darius Babusis
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, HIV/AIDS drug development and treatment, COVID-19 Clinical Research Studies, Respiratory viral infections research, Hepatitis C virus research
Most-Cited Works
- → Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV(2020)1,802 cited
- → Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses(2017)1,619 cited
- → Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys(2016)1,579 cited
- → Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice(2020)537 cited
- → Discovery of (S)-N-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide (Apremilast), a Potent and Orally Active Phosphodiesterase 4 and Tumor Necrosis Factor-α Inhibitor(2009)182 cited
- → Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy(2015)173 cited
- → Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024)(2003)146 cited
- → Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides(2012)138 cited
- → Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor(2021)132 cited
- → Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients(2013)125 cited